-
The FDA has approved the first fixed-dose combination product for the treatment of type 2 diabetes and hypercholesterolemia. This tablet combines a dipeptidyl peptidase-4 inhibitor (sitagliptin) and a HMG-CoA reductase inhibitor (simvastatin).
-
The oral administration of 500,000 IU cholecalciferol in fall or winter resulted in a slightly higher risk of falls and fractures vs placebo in 2,256 community-dwelling women aged 70 and above.
-
Death by suicide is a significant occupational hazard for physicians. This is strongly associated with professional burnout, which is characterized by a loss of emotional, mental, and physical energy due to continued job-related stress. Studies have identified three factors that are independently associated with burnout for both surgeons and internal medicine physicians hours worked per week, experiencing a work/home conflict within the last three weeks, and how the most recent work/home conflict was resolved.
-
It would be fair to say that nearly all formal clinical research begins before it is even recognized as such. Observant clinicians note patterns, or what appear to be patterns, in those they treat.
-
The term "reiki" (pronounced "ray-key") comes from two Japanese words, rei, meaning universal spirit, and ki, meaning life energy. Therapies based on this non-physical, vibrational life energy are known as biofield therapies, which include therapeutic touch and healing touch.
-
In a lengthy intervention trial, antibiotic prophylaxis against recurrent urinary tract infections in premenopausal women was more effective than a cranberry extract; however, development of antibiotic resistance was significant.
-
Screening for lung cancer by means of chest X-ray (CXR) does not reduce mortality, even with the addition of sputum cytology.
-
The use of aspirin for the primary prevention of cardiovascular (CV) disease remains controversial.
-
Interpret the rhythm strip shown above. Does it represent complete (3rd degree) AV Block? How would you proceed clinically?
-
A randomized, controlled trial of persons with new onset common cold showed modest effects of placebo on duration and severity of the cold symptoms, but greater effects among the patients who believe in the benefits of echinacea, whether receiving the supplement or placebo.
